Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein, Inc. (NASDAQ: HSIC) generates a steady flow of news as a FORTUNE 500 and S&P 500® health care solutions company serving office-based dental and medical practitioners. As a medical, dental, and hospital equipment and supplies merchant wholesaler with a significant technology footprint, the company issues updates that cover financial performance, leadership changes, partnerships, and product and technology developments.
Investors following HSIC news will find regular earnings and guidance announcements, including quarterly financial results and updates on sales growth across its Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology segments. These releases often highlight trends in dental and medical distribution, specialty dental products, and technology adoption, as well as commentary on strategic initiatives such as the company’s BOLD+1 strategy and value creation programs.
Henry Schein news also includes leadership and governance updates, such as the announced retirement of long-time CEO Stanley M. Bergman from the chief executive role and the appointment of Frederick M. Lowery as the company’s next CEO, effective March 2, 2026. These items provide insight into succession planning and the company’s approach to long-term leadership continuity.
Another key theme in HSIC coverage is technology and innovation in dental practice management. Through Henry Schein One, the company reports on new AI-enabled workflows, embedded automation, and collaborations with partners like Amazon Web Services and VideaHealth. News items describe developments in practice management platforms such as Dentrix and Dentrix Ascend, including AI-driven documentation, imaging, and revenue cycle tools.
In addition, Henry Schein announces strategic partnerships and distribution agreements, such as its expanded relationship with vVARDIS for the Curodont Repair Fluoride Plus product across U.S. dental segments. These stories shed light on how the company broadens its product offerings and supports dental professionals with new clinical options.
For investors, analysts, and health care professionals, the HSIC news feed on Stock Titan offers a centralized view of these corporate developments, helping users monitor how Henry Schein’s distribution, specialty products, and technology initiatives evolve over time.
Summary not available.
Summary not available.
Henry Schein, Inc. (NASDAQ: HSIC) is set to host its inaugural in-person THRIVE LIVE™ event from April 7-9 at the Bellagio Hotel & Casino in Las Vegas, NV. This premier educational gathering will focus on the latest in dental technology, offering clinicians and their teams opportunities to learn from industry leaders and network with peers. The event will also integrate the Business of Dentistry conference, enhancing the educational value for attendees. The initiative underscores Henry Schein's commitment to equipping dental professionals with vital knowledge for effective practice management.
Henry Schein, a leading provider of healthcare solutions, will release its fourth quarter and full-year 2021 financial results on February 15, 2022, prior to market opening. A live webcast of the earnings call will begin at 10:00 a.m. ET, featuring speeches from executives including CEO Stanley M. Bergman and CFO Steven Paladino. The call will be accessible via the company's webcast link. Henry Schein operates globally, supporting over 1 million customers with a comprehensive range of healthcare solutions.
Henry Schein, Inc. (NASDAQ: HSIC) announced the retirement of CFO Steven Paladino, effective April 29, 2022, after 35 years with the company. Ronald N. South, currently Vice President of Corporate Finance, will succeed him. Paladino will remain on the Board of Directors and serve as an advisor post-retirement. Under Paladino's leadership, the company experienced significant growth, achieving a compound annual growth rate of approximately 12% in net sales and earnings per share since going public in 1995. The transition aims to ensure continuity in financial management.
Henry Schein, the leading provider of healthcare solutions for dental and medical practitioners, will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 9:45 a.m. Eastern time. The event will be accessible via live webcast on Henry Schein's investor relations website. As a FORTUNE 500 Company and member of the S&P 500 index, Henry Schein reported sales of $10.1 billion in 2020, with a consistent compound annual growth rate of 12% since going public in 1995. For additional details, visit their website.
Henry Schein, Inc. (Nasdaq: HSIC) announced that CEO Stanley M. Bergman received an award from The National Hispanic Foundation for his efforts in promoting health equity for Hispanic communities. The recognition occurred during the 18th Annual New York Hispanic Health Professional Student Scholarship Gala. Bergman emphasized the company's commitment to reducing health disparities and improving access to healthcare. Over three decades, Henry Schein has partnered with organizations to foster diversity in healthcare and support the recruitment of Hispanic professionals.
Summary not available.
Henry Schein (NASDAQ: HSIC) has signed a cooperative contract with OMNIA Partners to enhance procurement access for K-12, higher education, and healthcare sectors. This agreement includes a master contract with the University of California, facilitating medical supply distribution to eligible public agencies. The offerings include point-of-care diagnostic testing, PPE, and various medical products. The contract aims to streamline procurement, increase savings, and improve health services accessibility for students and staff.
Summary not available.